Treatment with tyrosine kinase inhibitors for patients with differentiated thyroid cancer: the M. D. Anderson experience. [electronic resource]
Producer: 20100701Description: 2588-95 p. digitalISSN:- 1945-7197
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents -- administration & dosage
- Benzenesulfonates -- administration & dosage
- DNA Mutational Analysis
- Disease Progression
- Disease-Free Survival
- Female
- Humans
- Indoles -- administration & dosage
- Kaplan-Meier Estimate
- Male
- Middle Aged
- Neoplasm Metastasis
- Niacinamide -- analogs & derivatives
- Off-Label Use
- Phenylurea Compounds
- Protein Kinase Inhibitors -- administration & dosage
- Protein-Tyrosine Kinases -- antagonists & inhibitors
- Pyridines -- administration & dosage
- Pyrroles -- administration & dosage
- Sorafenib
- Sunitinib
- Survival Analysis
- Thyroglobulin -- blood
- Thyroid Neoplasms -- diagnostic imaging
- Tomography, X-Ray Computed
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.